Please login to the form below
Death leads to recall of batch of Takeda's Rienso in Switzerland
Marketing partner Amag also reports three other hypersensitivity reactions
Astellas gets first OK for prostate drug Vesomni
Approved in the Netherlands to treat men with lower urinary tract symptoms
Merck & Co inches closer to US green light for insomnia drug
FDA panel backs suvorexant, although some concerns about high dosages
GSK awarded $200m by US government for antibiotic research
Follows state-supported schemes in Europe to combat resistance to antibiotics
David Nicholson to step down as head of England’s NHS
Decision to retire comes two months after publication of Francis report into hospital scandal
Roche repeats cancer drugs warning as Avastin faces another NICE rejection
Concerns about future of Cancer Drugs Fund
Italian pharma market set for continued downturn
Will fall $1.6bn in value by 2020, says analyst GlobalData
Novartis wins third NICE recommendation for Lucentis
Gains final backing to treat NHS patients with macular oedema
France ignores EMA and suspends Bayer's Diane 35
National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict
Informational source shift: from marketing to medical
The changing role of medical information in HCP communications pathways
-
Chasing the cure for Parkinson's diseaseResearch for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms
-
From paralysis to analysis: the journey to multichannel marketingTo make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier
-
ClinTec International expands into Turkey
CRO says new office will bolster its presence in the Middle East and North Africa
-
Royalty Pharma raises Elan bid as deals keep comingValues Elan at about $6.5bn
-
Pfizer pulls late-stage trial of cancer drug in NHLInotuzumab ozogamicin fails to show survival benefit in phase III
-
Actavis to buy Warner Chilcott in $8.5bn dealCombined company will have annual revenues of about $11bn
-
Healthcare at Home and QED partner on orphan diseases
OrphanReach alliance will see companies provide product lifecycle services
-
New vortioxetine studies reinforce efficacy in depressionSupports marketing applications from Takeda and Lundbeck
-
India puts cost controls on medicinesDrugs (Prices Control) Order 2013 reduces price of hundreds of drugs
Latest appointments
-
Travyn Rhall takes global CEO role at Millward BrownRhall moves into role following successful seven-year stint as CEO, AMP
-
Edelman appoints Red Health's Paul GittinsFounding member of Red Health to move to Edelman as managing director
-
Clare Gerada to step down as UK RCGP chairMaureen Baker nominated as chair-elect
-
Health editor at The Sun newspaper joins Ruder FinnEmma Morton appointed media strategist at PR firm
-
Boehringer's Wolfram Carius to step downHe will be replaced by Wolfgang Baiker on the board of managing directors
Featured jobs
- Senior Brand Manager - Harlow
- Competitive
- Sales Manager - Media Publishing – Cheshire
- 25,000 to 35,000 per annum
- UK Marketing Director
- 80,000 to 100,000 per annum
- Group Account Director –Healthcare Advertising
- Neg
Subscribe to our email news alerts
- Achieving an aligned business intelligence capability - fact or fiction?
- Global biosimilars market to reach $2.45bn in 2013
- Bringing trial data out of the shadows
- Novartis gets FDA green light for new Ilaris indication
- Brazil eHealth pilot improves healthcare access for city poor
- Amgen and Novartis partner with biotech venture capital firm
- Travyn Rhall takes global CEO role at Millward Brown
- Death leads to recall of batch of Takeda's Rienso in Switzerland
- Astellas gets first OK for prostate drug Vesomni
- Edelman appoints Red Health's Paul Gittins
- Merck & Co inches closer to US green light for insomnia drug
- GSK awarded $200m by US government for antibiotic research
PMHub
Add my companySuccinct Healthcare Communications
Succinct Healthcare Communications is a name synonymous with excellence and understanding in our chosen areas of expertise.Our mission is ...
Latest intelligence
- Clinical trial regulation in Mexico
- Regulatory improvements make Mexico an appealing destination for clinical trials outsourcing...
- How can pharma deliver returns on increased digital investment?
- Independent online professional networks work best as part of a multi-channel campaign ...
- The impact of Hollande's healthcare reforms in France
- A tougher environment for pharma, with market access and regulatory challenges...
Quick links
